Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018

Background: Heart failure (HF) accounts for a significant proportion of morbidity, mortality, and health care costs among older adults in the United States. We evaluated trends in clinical outcomes and the economic burden of HF hospitalizations in older patients (≥80 years). Methods: This analysis included data from the National Inpatient Sample between January 2004 and December 2018. We examined the trends of clinical characteristics, inpatient mortality, and health care cost utilization in older US adults for HF hospitalizations. Results: We identified 6 034 951 weighted HF hospitalizations for older adults (3527 per 100 000 person-years). After an initial decline in HF hospitalizations per 100 000 older US older adults from 4211 in 2004 to 3089 in 2014, there was increase to 3388 in 2018 (P trend <0.001 for both). There was an overall increase in cardiometabolic and chronic comorbidities during the study period. Overall, inpatient mortality was 4.7%; the adjusted inpatient mortality decreased from 6.1% in 2004 to 3.6% in 2018 (P trend <0.001). There was a decrease in adjusted mean length of stay (from 6.0 days in 2004 to 4.7 days in 2018) and adjusted inflation-adjusted care costs (from $11 865 in 2004 to $9677 in 2018) during the study period (P trend <0.001 for both). In comparison with younger adults (<80 years), older adults had higher inpatient mortality (4.7% versus 2.2%) but lower inflation-adjusted care costs ($10 587 versus $14 088). Conclusions: This 15-year national data suggests that despite a higher comorbidity burden and the recent increase in hospitalizations for HF in older patients, there has been an encouraging trend towards lower inpatient mortality, health care cost, and hospital length of stay among older adults in the United States.

[1]  M. Khan,et al.  Trends in Hospitalizations for Heart Failure, Acute Myocardial Infarction, and Stroke in the United States from 2004-2018. , 2021, American heart journal.

[2]  G. Fonarow,et al.  National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2017. , 2021, JAMA cardiology.

[3]  M. Alkhouli,et al.  Trends of Clinical Outcomes and Health Care Resource Use in Heart Failure in the United States , 2020, Journal of the American Heart Association.

[4]  D. Holmes,et al.  Contemporary trends in the management of aortic stenosis in the USA. , 2020, European heart journal.

[5]  G. Fonarow,et al.  National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients. , 2019, The American journal of medicine.

[6]  Yuling Hong,et al.  National Burden of Heart Failure Events in the United States, 2006 to 2014 , 2018, Circulation. Heart failure.

[7]  J. H. Patterson,et al.  Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. , 2018, Journal of the American College of Cardiology.

[8]  G. Fonarow,et al.  The Hospital Readmissions Reduction Program: Evidence for Harm. , 2018, JACC. Heart failure.

[9]  C. Yancy,et al.  Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines–Heart Failure Registry , 2018, Circulation. Heart failure.

[10]  G. Felker,et al.  Inpatient Management of Heart Failure: Are We Shooting at the Right Target? , 2017, Annals of Internal Medicine.

[11]  Anita Deswal,et al.  Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[12]  W. Laskey,et al.  Mortality Among Patients Hospitalized With Heart Failure and Diabetes MellitusCLINICAL PERSPECTIVE , 2016 .

[13]  Vicki Stagg,et al.  ELIXHAUSER: Stata module to calculate Elixhauser index of comorbidity , 2015 .

[14]  M. Petzold,et al.  Does the target dose of neurohormonal blockade matter for outcome in Systolic heart failure in octogenarians? , 2015, International journal of cardiology.

[15]  U. Laufs,et al.  Age-related medication adherence in patients with chronic heart failure: A systematic literature review. , 2015, International journal of cardiology.

[16]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[17]  L. Allen,et al.  Aging of the United States Population: Impact on Heart Failure , 2012, Current Heart Failure Reports.

[18]  J. Steiner,et al.  Acculturation and Outcomes Among Patients With Heart Failure , 2012, Circulation. Heart failure.

[19]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[20]  Harlan M Krumholz,et al.  National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. , 2011, JAMA.

[21]  J. Juliard [Heart failure in the elderly]. , 2009, La Revue du praticien.

[22]  G. Fonarow,et al.  High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. , 2007, Journal of cardiac failure.

[23]  Hude Quan,et al.  Comparison of the Elixhauser and Charlson/Deyo Methods of Comorbidity Measurement in Administrative Data , 2004, Medical care.

[24]  Albert W Wu,et al.  Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. , 2003, Journal of the American College of Cardiology.

[25]  王德伦,et al.  英语-翻译-Internet , 2000 .